Biomedical subjects
S SHERRY
Publications and source records attributed to S SHERRY.
Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
Explore the source record for details and available documents.
Impairment of hemostasis in the urinary tract: the role of urokinase.
Explore the source record for details and available documents.
Thrombolytic activity and related phenomena. Status of therapy: critique and outlook for the future.
Explore the source record for details and available documents.
A comparison of the fibrinolytic and fibrinogenolytic effects of plasminogen activators and proteolytic enzymes in plasma.
Explore the source record for details and available documents.
Evaluation of human fibrinolysin (actase); lack of fibrinolytic activity after intravenous administration in man.
Explore the source record for details and available documents.
Thrombolytic (fibrinolytic) therapy for coronary heart disease.
Explore the source record for details and available documents.
Studies on the thrombolytic activity of human plasma.
Explore the source record for details and available documents.
Fibrinolysis and fibrinolytic activity in man.
Explore the source record for details and available documents.
Studies on enhanced fibrinolytic activity in man.
Explore the source record for details and available documents.
The mechanism of clot dissolution by plasmin.
Explore the source record for details and available documents.
The maintenance of a sustained thrombolytic state in man. I. Induction and effects.
Explore the source record for details and available documents.
The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders.
Explore the source record for details and available documents.
Possibilities for therapy with enzymes.
Explore the source record for details and available documents.
Developments in fibrinolytic therapy for thrombo-embolic disease.
Explore the source record for details and available documents.
xi-Aminocaproic acid: an inhibitor of plasminogen activation.
Explore the source record for details and available documents.
The clearance of heterologous protein from the circulation of normal and immunized man.
Explore the source record for details and available documents.
The activation of human plasminogen. I. Spontaneous activation in glycerol.
Explore the source record for details and available documents.